BrUOG 318: FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Feb 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2020.
- 01 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2020.
- 28 Jun 2016 Status changed from not yet recruiting to recruiting.